Thomas J. Schall Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas J. Schall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas J. Schall. Thomas J. Schall is President and CEO in ChemoCentryx, Inc. ($CCXI).
Latest Insider Trading Transactions of Thomas J. Schall
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 11.03 | 32,873 | 362,451 | 2,184,994 | 2.2 M to 2.2 M (-1.48 %) |
May 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 32,873 | 197,238 | 2,217,867 | 2.2 M to 2.2 M (+1.50 %) |
May 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 11.00 | 17,127 | 188,407 | 2,184,994 | 2.2 M to 2.2 M (-0.78 %) |
May 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 6.00 | 17,127 | 102,762 | 2,202,121 | 2.2 M to 2.2 M (+0.78 %) |
Mar 07 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 10.86 | 290,000 | 3,149,400 | 290,000 | |
Mar 07 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 90,000 | 0 | 90,000 | |
Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 66,667 | |
Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 33,334 | |
Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 5.95 | 36,717 | 218,466 | 2,184,994 | 2.2 M to 2.2 M (-1.65 %) |
Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,221,711 | 2.2 M to 2.2 M (+1.52 %) |
Jan 03 2018 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,188,378 | 2.2 M to 2.2 M (+1.55 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.00 | 33,333 | 0 | 66,667 | |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Payment of Exercise | F | 7.40 | 17,955 | 132,867 | 2,155,045 | 2.2 M to 2.2 M (-0.83 %) |
Jan 04 2017 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.00 | 33,333 | 0 | 2,173,000 | 2.1 M to 2.2 M (+1.56 %) |
Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 3.57 | 300,000 | 1,071,000 | 300,000 | |
Mar 09 2016 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 6,527 | 3,916 | 0 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 16,540 | 9,924 | 6,527 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 1,200 | 720 | 23,067 | |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.36 | 6,527 | 48,047 | 2,148,667 | 2.2 M to 2.1 M (-0.30 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 6,527 | 3,916 | 2,155,194 | 2.1 M to 2.2 M (+0.30 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.55 | 16,540 | 124,920 | 2,148,667 | 2.2 M to 2.1 M (-0.76 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 16,540 | 9,924 | 2,165,207 | 2.1 M to 2.2 M (+0.77 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.51 | 1,200 | 9,009 | 2,148,667 | 2.1 M to 2.1 M (-0.06 %) |
Apr 01 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 1,200 | 720 | 2,149,867 | 2.1 M to 2.1 M (+0.06 %) |
Mar 27 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 900 | 540 | 24,267 | |
Mar 27 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.57 | 900 | 6,812 | 2,148,667 | 2.1 M to 2.1 M (-0.04 %) |
Mar 27 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 900 | 540 | 2,149,567 | 2.1 M to 2.1 M (+0.04 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 16,765 | 10,059 | 25,167 | |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 19,291 | 11,575 | 41,932 | |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 14,315 | 8,589 | 61,223 | |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.80 | 16,765 | 130,839 | 2,148,667 | 2.2 M to 2.1 M (-0.77 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 16,765 | 10,059 | 2,165,432 | 2.1 M to 2.2 M (+0.78 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.77 | 19,291 | 149,858 | 2,148,667 | 2.2 M to 2.1 M (-0.89 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 19,291 | 11,575 | 2,167,958 | 2.1 M to 2.2 M (+0.90 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.00 | 14,315 | 114,458 | 2,148,667 | 2.2 M to 2.1 M (-0.66 %) |
Mar 24 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 14,315 | 8,589 | 2,162,982 | 2.1 M to 2.2 M (+0.67 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 8,467 | 5,080 | 75,538 | |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 9,679 | 5,807 | 84,005 | |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.24 | 8,467 | 69,794 | 2,148,667 | 2.2 M to 2.1 M (-0.39 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 8,467 | 5,080 | 2,157,134 | 2.1 M to 2.2 M (+0.39 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.42 | 9,679 | 81,516 | 2,148,667 | 2.2 M to 2.1 M (-0.45 %) |
Mar 20 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 9,679 | 5,807 | 2,158,346 | 2.1 M to 2.2 M (+0.45 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 8,590 | 5,154 | 93,684 | |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 22,726 | 13,636 | 102,274 | |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.58 | 8,590 | 73,692 | 2,148,667 | 2.2 M to 2.1 M (-0.40 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 8,590 | 5,154 | 2,157,257 | 2.1 M to 2.2 M (+0.40 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 8.54 | 22,726 | 194,128 | 2,148,667 | 2.2 M to 2.1 M (-1.05 %) |
Mar 18 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 22,726 | 13,636 | 2,171,393 | 2.1 M to 2.2 M (+1.06 %) |
Feb 25 2015 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 8.19 | 420,000 | 3,439,800 | 420,000 | |
May 02 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 27,726 | 16,636 | 0 | |
May 02 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 5.59 | 27,726 | 154,875 | 2,148,667 | 2.2 M to 2.1 M (-1.27 %) |
May 02 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 27,726 | 16,636 | 2,176,393 | 2.1 M to 2.2 M (+1.29 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 14,041 | 8,425 | 27,726 | |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 18,233 | 10,940 | 41,767 | |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 5.46 | 14,041 | 76,595 | 2,148,667 | 2.2 M to 2.1 M (-0.65 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 14,041 | 8,425 | 2,162,708 | 2.1 M to 2.2 M (+0.65 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 5.33 | 18,233 | 97,127 | 2,148,667 | 2.2 M to 2.1 M (-0.84 %) |
Apr 30 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 18,233 | 10,940 | 2,166,900 | 2.1 M to 2.2 M (+0.85 %) |
Mar 19 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 60,000 | |
Mar 19 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.25 | 20,000 | 145,000 | 2,148,707 | 2.2 M to 2.1 M (-0.92 %) |
Mar 19 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 20,000 | 12,000 | 2,168,707 | 2.1 M to 2.2 M (+0.93 %) |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 7.10 | 395,000 | 2,804,500 | 395,000 | |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 80,000 | |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 7.05 | 20,000 | 140,932 | 2,148,707 | 2.2 M to 2.1 M (-0.92 %) |
Feb 20 2014 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Buy | M | 0.60 | 20,000 | 12,000 | 2,168,707 | 2.1 M to 2.2 M (+0.93 %) |
Jul 26 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 14.28 | 165,000 | 2,356,200 | 165,000 | |
Jul 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.54 | 2,585 | 37,595 | 2,148,687 | 2.2 M to 2.1 M (-0.12 %) |
Jul 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.37 | 19,504 | 280,360 | 2,151,272 | 2.2 M to 2.2 M (-0.90 %) |
Jul 03 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.50 | 311 | 4,510 | 2,170,776 | 2.2 M to 2.2 M (-0.01 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.04 | 7,600 | 106,728 | 2,171,087 | 2.2 M to 2.2 M (-0.35 %) |
May 17 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.04 | 7,600 | 106,728 | 2,171,087 | 2.2 M to 2.2 M (-0.35 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.02 | 2,312 | 32,409 | 2,178,687 | 2.2 M to 2.2 M (-0.11 %) |
Apr 12 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 217 | 3,038 | 2,180,999 | 2.2 M to 2.2 M (-0.01 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 200 | 2,800 | 2,181,216 | 2.2 M to 2.2 M (-0.01 %) |
Apr 02 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 556 | 7,784 | 2,181,416 | 2.2 M to 2.2 M (-0.03 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.75 | 75 | 1,031 | 2,181,972 | 2.2 M to 2.2 M (0.00 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.18 | 4,215 | 59,763 | 2,182,047 | 2.2 M to 2.2 M (-0.19 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.11 | 1,772 | 24,998 | 2,186,262 | 2.2 M to 2.2 M (-0.08 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.07 | 1,790 | 25,192 | 2,188,034 | 2.2 M to 2.2 M (-0.08 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.02 | 1,649 | 23,118 | 2,189,824 | 2.2 M to 2.2 M (-0.08 %) |
Mar 19 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.07 | 7,300 | 102,721 | 2,191,473 | 2.2 M to 2.2 M (-0.33 %) |
Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 422 | 5,908 | 2,198,773 | 2.2 M to 2.2 M (-0.02 %) |
Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,980 | 27,720 | 2,199,195 | 2.2 M to 2.2 M (-0.09 %) |
Mar 14 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 2,503 | 35,042 | 2,201,175 | 2.2 M to 2.2 M (-0.11 %) |
Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,100 | 15,405 | 2,203,678 | 2.2 M to 2.2 M (-0.05 %) |
Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,200 | 16,804 | 2,204,778 | 2.2 M to 2.2 M (-0.05 %) |
Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,573 | 22,025 | 2,205,978 | 2.2 M to 2.2 M (-0.07 %) |
Mar 11 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 3,075 | 43,050 | 2,207,551 | 2.2 M to 2.2 M (-0.14 %) |
Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 1,154 | 16,156 | 2,210,626 | 2.2 M to 2.2 M (-0.05 %) |
Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.25 | 105 | 1,496 | 2,211,780 | 2.2 M to 2.2 M (0.00 %) |
Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.03 | 500 | 7,016 | 2,211,885 | 2.2 M to 2.2 M (-0.02 %) |
Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.03 | 318 | 4,463 | 2,212,385 | 2.2 M to 2.2 M (-0.01 %) |
Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.05 | 400 | 5,618 | 2,212,703 | 2.2 M to 2.2 M (-0.02 %) |
Mar 06 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 14.00 | 3,064 | 42,896 | 2,213,103 | 2.2 M to 2.2 M (-0.14 %) |
Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.78 | 5,982 | 82,421 | 2,216,167 | 2.2 M to 2.2 M (-0.27 %) |
Mar 01 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 13.50 | 9,018 | 121,743 | 2,222,149 | 2.2 M to 2.2 M (-0.40 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.06 | 7,500 | 90,474 | 2,231,167 | 2.2 M to 2.2 M (-0.34 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.01 | 999 | 11,997 | 2,238,667 | 2.2 M to 2.2 M (-0.04 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.02 | 1,101 | 13,232 | 2,239,666 | 2.2 M to 2.2 M (-0.05 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 2,000 | 24,000 | 2,240,767 | 2.2 M to 2.2 M (-0.09 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.18 | 3,400 | 41,423 | 2,242,767 | 2.2 M to 2.2 M (-0.15 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.75 | 15,000 | 191,250 | 2,246,167 | 2.3 M to 2.2 M (-0.66 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Gift | G | 0.00 | 18,000 | 0 | 2,261,167 | 2.3 M to 2.3 M (-0.79 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.01 | 15,000 | 180,161 | 2,279,167 | 2.3 M to 2.3 M (-0.65 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 7,500 | 90,000 | 2,294,167 | 2.3 M to 2.3 M (-0.33 %) |
Oct 03 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 11.53 | 15,000 | 172,955 | 2,301,667 | 2.3 M to 2.3 M (-0.65 %) |
Jul 26 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 14.31 | 485,088 | 6,941,609 | 485,088 | |
Feb 29 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 10.27 | 175,000 | 1,797,250 | 175,000 |